Pages that link to "Q40668644"
Jump to navigation
Jump to search
The following pages link to Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes (Q40668644):
Displaying 32 items.
- Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia (Q24800882) (← links)
- A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma (Q24814644) (← links)
- Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas (Q24814838) (← links)
- RNA-Based Vaccines in Cancer Immunotherapy (Q26776028) (← links)
- Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells. (Q34559012) (← links)
- Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients (Q34994511) (← links)
- Cancer immunotherapy with mRNA-transfected dendritic cells (Q35826417) (← links)
- RNA transfer and its use in dendritic cell-based immunotherapy (Q36065947) (← links)
- In vitro preparation and functional assessment of human monocyte-derived dendritic cells-potential antigen-specific modulators of in vivo immune responses (Q36176649) (← links)
- Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells (Q36194575) (← links)
- Antigen-specific cellular immunotherapy of leukemia. (Q36240201) (← links)
- Dendritic cell vaccine strategies for renal cell carcinoma (Q36717351) (← links)
- DC-based cancer vaccines (Q36809780) (← links)
- The evolving role of dendritic cells in cancer therapy (Q37687418) (← links)
- Dendritic cell preparation for immunotherapeutic interventions. (Q37773266) (← links)
- mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic. (Q38071900) (← links)
- Dendritic cell vaccine against leukemia: advances and perspectives (Q38210813) (← links)
- Allogeneic mRNA-based electrotransfection of autologous dendritic cells and specific antitumor effects against osteosarcoma in rats (Q39306532) (← links)
- Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune Response (Q39791507) (← links)
- Enhanced antitumor effects by the coculture of allotumor RNA-pulsed dendritic cells with autologous cytokine-induced killer cells on hormone-refractory prostate cancer (Q40064005) (← links)
- T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation (Q42987508) (← links)
- Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity (Q43047446) (← links)
- Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma. (Q45867029) (← links)
- Induction of chronic lymphocytic leukemia (CLL)–specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells (Q47387344) (← links)
- A generic RNA pulsed DC based approach for developing therapeutic intervention against nasopharyngeal carcinoma (Q48919218) (← links)
- CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC? (Q50471175) (← links)
- Impact of transfection with total RNA of K562 cells upon antigen presenting, maturation, and function of human dendritic cells from peripheral blood mononuclear cells. (Q51064979) (← links)
- Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses. (Q54321271) (← links)
- Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts (Q60342834) (← links)
- Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes (Q61882108) (← links)
- The promise of cancer vaccines (Q80038678) (← links)
- Induction of antigen-specific cytotoxic T lymphocytes by using monocyte-derived DCs transfected with in vitro-transcribed WT1 or SART1 mRNA (Q82845503) (← links)